Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
TROP-2-targeted antibody-drug conjugate
Welcome,
Profile
Billing
Logout
Companies
Products
Products
Diseases
Trials
News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
12
24
36
48
60
72
84
96
108
120
Trodelvy
(sacituzumab govitecan-hziy) / Gilead
datopotamab deruxtecan
(DS-1062a) / Daiichi Sankyo, AstraZeneca
sacituzumab tirumotecan
(MK-2870) / Merck (MSD)
SHR-A1921
/ Jiangsu Hengrui Pharma
SHR-A2009
/ Jiangsu Hengrui Pharma
ESG401
/ Escugen Biotechnology, Sorrento
BAT8008
/ Bio-Thera Solutions
BL-M02D1
/ Biokin Pharma
MHB036C
/ Minghui Pharma
BAT8003
/ Bio-Thera Solutions
BHV-1510
/ Biohaven
F0024
/ Shanghai Fudan-Zhangjiang
BIO-106
/ BiOneCure
BNT325
/ BioNTech
JS108
/ Shanghai Junshi Biosci, Hangzhou DAC Biotech
LCB84
/ J&J
PF-06664178
/ Pfizer
